What is the price-to-earnings ratio of Conmed?
The price-earnings ratio of Conmed is currently 12.03.
Conmed P/E 2025
Conmed P/E
12.03
Ticker
CNMD
ISIN
US2074101013
WKN
886793
As of Jul 31, 2025, Conmed's P/E ratio was 12.03, a -25.28% change from the 16.1 P/E ratio recorded in the previous year.
The Conmed P/E history
Conmed Aktienanalyse
What does Conmed do?
Conmed Corporation is a leading medical technology company that offers a wide range of surgical instruments and devices for the fields of gastroenterology, endoscopy, orthopedics, gynecology, and electro surgery. The company was founded in 1970 and is headquartered in Utica, New York. The history of Conmed Corp began with the founding of Consolidated Medical Equipment, Inc. (CME) in 1970. The company initially started its business with the distribution of surgical instruments and devices for medical applications and quickly expanded in this field. In the 1980s, the company went public. In the 1990s, the company changed its name to Conmed Corporation and expanded its activities into the field of electro surgery, which has since become a major growth driver for the company. Today, Conmed Corp operates multiple manufacturing facilities worldwide and has sales offices in over 50 countries. The company is divided into four main business segments: gastroenterology, endoscopy, orthopedics, and electro surgery. The gastroenterology segment includes products for the diagnosis and treatment of gastrointestinal disorders, such as endoscopes, biopsy instruments, dilation balloons, trocars, and shears. In the endoscopy segment, Conmed Corp offers products for the diagnosis and treatment of digestive tract disorders, including endoscopes, biopsy instruments, dilation balloons, trocars, and shears. The orthopedics segment includes a wide range of surgical instruments and devices for the treatment of musculoskeletal disorders, including implants, bandages, bone plates, intramedullary nails, and others. Finally, the electro surgery segment is the fastest-growing segment of Conmed Corp and includes a wide range of devices for precision surgery, including electrocautery, electro surgery, endoscopy, and laparoscopy devices. Conmed Corp aims to develop innovative medical technologies that meet the needs of patients and healthcare professionals. The company places great emphasis on producing high-quality products that are reliable and safe. Conmed Corp is a successful company that continues to evolve and expand its product range to meet the rapidly evolving needs of the medical community. Conmed ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Conmed's P/E Ratio
The Price to Earnings (P/E) Ratio of Conmed is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Conmed's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Conmed is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Conmed’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Conmed stock
How has the price-earnings ratio of Conmed changed compared to last year?
The price-to-earnings ratio of Conmed has increased by -25.28% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Conmed high compared to other companies?
Yes, the price-to-earnings ratio of Conmed is high compared to other companies.
How does an increase in the price-earnings ratio of Conmed affect the company?
An increase in the price-earnings ratio of Conmed would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Conmed affect the company?
A decrease in the price-earnings ratio of Conmed would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Conmed?
Some factors that influence the price-earnings ratio of Conmed are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Conmed pay?
Over the past 12 months, Conmed paid a dividend of 0.8 USD . This corresponds to a dividend yield of about 1.6 %. For the coming 12 months, Conmed is expected to pay a dividend of 0.82 USD.
What is the dividend yield of Conmed?
The current dividend yield of Conmed is 1.6 %.
When does Conmed pay dividends?
Conmed pays a quarterly dividend. This is distributed in the months of October, January, May, July.
How secure is the dividend of Conmed?
Conmed paid dividends every year for the past 16 years.
What is the dividend of Conmed?
For the upcoming 12 months, dividends amounting to 0.82 USD are expected. This corresponds to a dividend yield of 1.63 %.
In which sector is Conmed located?
Conmed is assigned to the 'Health' sector.
Wann musste ich die Aktien von Conmed kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Conmed from 7/3/2025 amounting to 0.2 USD, you needed to have the stock in your portfolio before the ex-date on 6/13/2025.
When did Conmed pay the last dividend?
The last dividend was paid out on 7/3/2025.
What was the dividend of Conmed in the year 2024?
In the year 2024, Conmed distributed 0.8 USD as dividends.
In which currency does Conmed pay out the dividend?
The dividends of Conmed are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Conmed
Our stock analysis for Conmed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Conmed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
